KARYOPHARM THERAPEUTICS INC's ticker is and the CUSIP is 48576UAA4. A total of 20 filers reported holding KARYOPHARM THERAPEUTICS INC in Q4 2021. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $9,548,000 | -21.9% | 11,460,000 | -23.4% | 0.77% | -17.1% |
| Q4 2021 | $12,230,000 | +6.9% | 14,960,000 | 0.0% | 0.93% | -13.5% |
| Q3 2021 | $11,437,000 | -23.9% | 14,960,000 | -0.3% | 1.07% | -33.4% |
| Q2 2021 | $15,028,000 | +60.4% | 15,000,000 | +66.7% | 1.61% | +40.9% |
| Q1 2021 | $9,367,000 | – | 9,000,000 | – | 1.14% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Birch Grove Capital LP | 9,000,000 | $6,561,000 | 2.60% |
| HIGHBRIDGE CAPITAL MANAGEMENT LLC | 31,050,000 | $22,600,000 | 0.52% |
| Context Capital Management, LLC | 7,000 | $5,079,000 | 0.36% |
| DeepCurrents Investment Group LLC | 11,890,000 | $8,569,000 | 0.34% |
| DAVIDSON KEMPNER CAPITAL MANAGEMENT LP | 25,000,000 | $18,139,000 | 0.31% |
| CAPSTONE INVESTMENT ADVISORS, LLC | 5,500,000 | $4,046,000 | 0.02% |
| LAZARD ASSET MANAGEMENT LLC | 17,500,000 | $12,872,000 | 0.02% |
| BLB&B Advisors, LLC | 100,000 | $73,000 | 0.01% |
| MACKAY SHIELDS LLC | 221,000 | $163,000 | 0.00% |
| JPMORGAN CHASE & CO | 900,000 | $655,000 | 0.00% |